Go to the content. | Move to the navigation | Go to the site search | Go to the menu | Contacts | Accessibility

| Create Account

Caliari, Diego (2008) Valutazione dell'espressione di immunomarcatori nel tumore mammario felino. [Ph.D. thesis]

Full text disponibile come:

Documento PDF

Abstract (english)

The use of companion animals as a cancer model for human oncology is leading to a better understanding of many cancerogenic aspects and to new therapeutic approaches. The high incidence, the histopathology, some tumorigenic aspects and the estrogen-independency, make of the feline mammary carcinoma a suitable model for the study of hormonal-independent breast cancers. In the present work, immunohistochemical evaluations of the expression of hormonal receptors, of the oncogene HER-2, of the oncosoppresor p53, of different cytoplasmic filaments (cytokeratins, vimentin, alpha-smooth muscle actin), of calponin, and of the proliferation marker Ki67 have been performed on feline mammary neoplasia, hyperplastic/dysplastic lesions, and normal mammary gland in 81 queens. The results are compared with the morphological aspects of the tumours and with the anamnestic and the follow-up data. Data obtained have allowed general considerations about neoplastic categories and more specific considerations about the expression of each marker. The cytoplasmic filaments have been investigated to better understand the histogenetic aspects of the feline mammary tumour and to eventually evaluate the presence of a "basal-like" group of cancers as described in women. The expression of basal cytokeratins (cytokeratin 5/6 and 14), that showed a positive correlation, and the high incidence of vimentin expression might suggest a pluripotent cell, a basal cell or a terminal duct as origin of the mammary tumours in the cat. In addition, the analysis of a-sma , calponin, and ck14 showed the presence of a myoepithelial component that was not always detected in routine histological sections, even when highly malignant, allowing in this way a better classification of the lesions. Regarding expression of specific markers, lower expression levels of HER-2 than what described within literature were observed, suggesting that this gene might not play a fundamental role in the feline mammary tumours development. Ki-67 presented a significant difference in expression between neoplastic and hyperplastic lesions, it positively correlated with grading, survival, and p53 expression, confirming its well-known role as indicator of the biological behavior of a neoplastic population. Finally, evidence of a large group of hormone-independent feline mammary tumours confirms a general more aggressive nature of these neoplasia in the feline species.

Statistiche Download - Aggiungi a RefWorks
EPrint type:Ph.D. thesis
Tutor:Castagnaro, Massimo
Data di deposito della tesi:2008
Anno di Pubblicazione:2008
Key Words:immunoistochimica gatto mammari tumori
Settori scientifico-disciplinari MIUR:Area 07 - Scienze agrarie e veterinarie > VET/03 Patologia generale e anatomia patologica veterinaria
Struttura di riferimento:Dipartimenti > pre 2012 - Dipartimento di Sanità pubblica, Patologia comparata ed Igiene veterinaria
Codice ID:998
Depositato il:14 Oct 2008
Simple Metadata
Full Metadata
EndNote Format


I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

1. D.C. Allred, S.K. Mohsin, S.A.W. Fuqua, Histological and biological evolution of human premalignant breast disease, Endocrine-related cancer, 2001, 8: 47–61. Cerca con Google

2. F.V. Amorim, H.J. Souza, A.M. Ferreira, A.B. Fonseca, Clinical, cytological and histopathological evaluation of mammary masses in cats from Rio de Janeiro, Brazil, Journal of Feline Medicine and Surgery, 2006, 8(6): 379-88. Cerca con Google

3. J.Apostolou, G. Sarli, O. Capitani, P.S. Marcato, Considerazioni prognostiche su lesioni preneoplastiche e neoplastiche multiple della ghiandola mammaria del cane e del gatto, Veterinaria, 1998, 4. Cerca con Google

4. D.A. Arber, Effect of prolungated formalin fixation on the immunohistochemical reactivity of breast markers, Applied Immunohistochemistry and Molecular Morphology 2002,10(2): 183-6. Cerca con Google

5. M.V. Artufel, A.C. Valero, R.R. Llado, N.E. Sagales, M.C. Llorca, A.M. Carazo, C.C. Cardo, X.P. Torrus, Molecular protocol for HER2/neu analysis in breast carcinoma, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2005, 7(11): 504-11. Cerca con Google

A. Bànkfalvi, A. Ludwig, B. de-Hesselle, H. Buerger, I.B. Buchwalow, W. Boecker, Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases, Modern Pathology, 2004, 17(9):1051-61. Cerca con Google

6. R. Bartsch, C. Wenzel, C.C. Zielinski, G.G. Steger, HER-2-Positive Breast Cancer: Hope Beyond Trastuzumab, 2007, BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 21(2): 69-77. Cerca con Google

7. M. Bayaa, R.A. Booth, Y. Sheng, X.J. Liu, The classical progesterone receptor mediates Xenopus oocyte maturation through a nongenomic mechansim, Proceedings of the National Academy of Sciences of the United States of America, 2000, 97: 12607–12612. Cerca con Google

8. F. Behbod and J.M. Rosen, Will cancer cells provide new therapeutic targets?, Carcinogenesis, 2004, 26(4): 703-711. Cerca con Google

9. W. Bocker, B.Bier, A. Ludwig, Benign proliferative lesions and in situ carcinoma of the breast: new immunohistological findings and their biological implications, European journal of cancer prevention, 1993, 2:41–49. Cerca con Google

10. M.J. Bojrab, G.W. Ellison e B. Slocum. Tecnica chirurgica, volume 1, capitolo 36, pp.539-541, Utet 2004. Cerca con Google

11. V. Boonyaratanakornkit, M.P. Scott, V. Ribon, L. Sherman, S.M. Anderson, W.T. Miller, Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases, 2001, Molecular cell, 2001: 269–280. Cerca con Google

12. W.B. Carter, G. Niu, Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways, Cancer Research, 2007, 67(4): 1487-93. Cerca con Google

13. P. Casalini, M.V. Iorio, ERBB2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) ), Atlas Genet Cytogenet Oncol Haematol, 2004, URL : http://AtlasGeneticsOncology.org/Genes/ERBB2ID162ch17q11.html. Vai! Cerca con Google

14. M. Castagnaro, C. Casalone, E. Bozzetta, R. De Maria, B. Biolatti, M. Caramelli, Tumor grading and the one year post-surgical prognosis in feline mammary carcinomas, Journal of Comparative pathology, 1998, 119: 263-275. Cerca con Google

15. M. Castagnaro, C. Casalone, E. Bozzetta, R. De Maria, B. Biolatti, M. Caramelli, Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas, Research in Veterinary Science, 1998, 65: 223-226. Cerca con Google

16. P. Chappell, J.S. Schneider, P. Kim, M. Xu, J.P. Lydon, B.W. O’Malley, Absence of gonadotropin surges and gonadotropin releasing hormone self-priming in ovariectomized (ovx), estrogen (E2)- treated progesterone receptor knockout (PRKO) mice, 1999, Endocrinology 140: 3653-3658. Cerca con Google

17. R.T. Chatterton, J,P. Lydon, R.G. Metha, E.T. Mateo, A. Pletz, V.C. Jordan, Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12- dimethilbenzaanthracene-induced hormone-indiendent preneoplastc lesions in vitro, 2002, Cancer Letterature, 188: 47-52. Cerca con Google

18. Y. Cho, S. Gorina, P.D. Jeffrey, N.P. Pavletich, Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations, Science,1994, 265(5170): 334-5. Cerca con Google

19. D.R. Ciocca, M.A. Fanelli, Estrogen receptor and cell proliferation in breast cancer, Trends in endocrinology and metabolism, 1997, 8: 313-321. Cerca con Google

20. J.H. Clark, C.S. Watson, B.M. Markaverich, J.S. Syne, W.B. Panko, Heterogeneity of estrogen binding sites in mammary tumors, Breast Cancer Research and Treatment, 1983, 3(1): 61-5. Cerca con Google

21. H. Clayton, I. Titley, M.M. Vivano, Growth and differentiation of progenitor/stem cells derived from the human mammary gland, Experimental cell research, 2004, 297: 444-460. Cerca con Google

22. O.M. Conneely, B.M. Jericevic, J.P. Lydon, Progesterone receptors in mammary gland development and tumorigenesis, Journal of Mammary Gland Biology and Neoplasia, 2003, 2: 205- 214. Cerca con Google

23. C.G. Couto e R. W. Nelson., Medicina Interna del Cane e del Gatto, capitolo 58, pp.903-904, Elsevier, 2006. Cerca con Google

24. J.E. Crouch, M.B. Lackey, The mammary gland-Its structure, relationships and blood supply, Textatlas of Cat Anatomy, p.183, Eds Crouch JE & Lackey,1969. Cerca con Google

25. D. Dabbs, Diagnostic Immunohistochemistry, 2006, Second Edition Cerca con Google

26. D.J. Dabbs, A.M. Gown, Distribution of calponin and smooth muscle myosin heavy chain in fineneedle aspiration biopsies of the breast, Diagnostic Cytopathology, 1999, 20(4): 203-7. Cerca con Google

27. S. Damiani, M. Ludvikova, G. Tomasic, S. Bianchi, A.M. Gown, V. Eusebi, Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study, Virchows Archiv : an International Journal of Pthology.1999, 434(3): 227-34. Cerca con Google

28. G.S. Dalgin,G. Alexe, D. Scanfeld, P. Tamayo, J.P. Mesirov, S. Ganesan,C. DeLisi, G. Bhanot, Portraits of brest cancer progression, BMC Bioinformatics, 2007, 8: 291. Cerca con Google

29. K. M. Dameron, O.V. Volpert, M.A. Tainsky, N. Bounck, Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1, Science, 1994, 5178: 1582-1584. Cerca con Google

30. M. de las Mulas J, E. de los Monteros, M.J. Bautista, Gómez-Villamandos JC, Morales C. Immunohistochemical distribution pattern of intermediate filament proteins and muscle actin in feline and human mammary carcinomas, Journal of Comparative Pathology, 1994, 111(4): 365-81. Cerca con Google

31. H.D. Dellman e J.A. Eurell, Istologia e Anatomia Microscopica Veterinaria, capitolo 16, pp. 433- 434, Casa Editrice Ambrosiana, 2000. Cerca con Google

32. R. De Maria, M. Oliviero,S. Iussich, N. Munekazu, T. Murata, B. Biolatti, M.F. Di Renzo, Spontaneous Feline Mammayi Carcinoma is a Model of HER2 Overexpressing Poor Prognosis Human Breast Cancer, Cancer Research, 2005, 65(3). Cerca con Google

33. M.A. Deugnier, M.M. Faraldo, B. Janji, P. Rousselle, J.P. Thiery, M.A. Glukhova, EGF controls the in vivo development potential of a mammary epithelial cell line possessing progenitors properties, The Journal of Cell Biology., 2002 ,159(3): 453-63. Cerca con Google

34. V. Dieras, A. Vincent-Salomon, A. Degeorges, P. Beuzeboc, L. Mignot, P. De Cremoux, Trastuzumab (Herceptin) and breast cancer: mechanism of resistance, Bull Cancer, 2007, 94(3): 259-66. Cerca con Google

35. J.M. Dobson, J. Morris, Small Animal Oncology, 2001, pp.4-191. Cerca con Google

36. M. Dolores Pérez-Alenza, Á. Jiménez, A. I. Nieto, L, Peña: First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases Breast Cancer Research 2004, 6:R300-R307. Cerca con Google

37. Donnay, J. Raios, P. Wouters-Ballaman, N. Devlee Shouwer, G. Leclerq, J.P. Verstegen, Receptor for estrogen, progesterone and epidermal growth factor in normal ant tumorous canine mammary tissues, 1993, Journal of Reproduction and Fertility, Supp l 47: 501-512. Cerca con Google

38. C.R. Dorn, D.O.N. Taylor, R.Schneider, H.H. Hibbard., M.R. Klauber: Survey of animal neoplasm in Alameda and Contra Costa countries, California II .Cancer morbility in dogs and cats from Alameda country, Journal of national Cancer Institute, 1968, 40: 307-318. Cerca con Google

39. R. Dulbecco, W.R. Allen, M. Bologna, M. Bowman, Marker evolution during the development of the rat mammary gland: stem cells identified by markers and the role of myoepithelial cells, Cancer research, 1986, 46: 2449-2456. Cerca con Google

40. K.M. Dyce, W.O. Sack,C.J.G. Wensing, Testo di Anatomia Veterinaria, capitolo 14, pp.417-419, Antonio Delfino Editore, 2006. Cerca con Google

41. S.A. Eccles, The role of c-erbB-2/HER2/neu in Breast Cancer Progression and Metastasis, Journal of Mammary Gland Biology and Neoplasia, 2004, 4: 393-406. Cerca con Google

42. C.W. Elston, I.O.Ellis: Tumors of the breast. In Diagnostic Histopathology of Tumors, C.D.M. Fletcher, 635-689 ed. Churchill Livingstone, New York, 1991. Cerca con Google

A. Espinosa Los de Monteros, M.Y. Millán, J. Ordás, L. Carrasco, C. Reymundo, J. Martín Las de Mulas, Immunolocalization of the smooth muscle-specific protein calponin in complex and mixed tumors of the mammary gland of the dog: assessment of the morphogenetic role of the myoepithelium, Veterinary Pathology, 2002, 39(2): 247-56. Cerca con Google

43. N. Fausto, A.K. Abbas, V. Kumar, Pathologic Basis of disease 7th edition, 2005, capitolo 23, pp.1136-1137. Cerca con Google

44. D.G. Feldman, L. Gross, Electron microscopic study of spontaneous mammary carcinomas in cats and dogs: Virus-like particles in cat mammary carcinomas. Cancer Research, 1971, 31: 1261-1267. Cerca con Google

45. S.A.W. Fuqua, The role of estrogen receptor in breast cancer metastasis. Journal of Mammary gland Biology and Neoplasia, 2001, 6(4): 407-417. Cerca con Google

46. G. Gasparini, Prognostic Value of Vascular Endothelial Growth Factor in Breast Cancer, The Oncologist, 2000, Vol. 5, Suppl 1, 37-44. Cerca con Google

47. A.P. Gouvea, F. Milanezi, S.J. Olson, D. Leitao, F.C. Schmitt, H. Gobbi, Selecting antibodies to detect HER2 overexpression by immunohistochemistry in invasive mammary carcinomas. Applied Immunohistochemistry and Molecular Morphology, 2006, 14(1):103-8 Cerca con Google

48. V.E. Gould, W. Jao, H. Battifora, Ultrastructural analysis in the differential diagnosis of breast tumors: the significance of myoepithelial cells, basal lamina, intracytoplasmic lumina and secretory granules, Pathology, research and practice, 1980, 167: 45-57. Cerca con Google

49. V. E. Gould, G. K. Koukoulis, D. S. Jansson, R. B. Nagle, W. W. Franke, R. Moll, Coexpression patterns of vimentin and glial filament protein with cytokeratin in normal, hyperplastic and neoplastic breast, American Journal of Pathology, 1990, 137(5): 1143–1155. Cerca con Google

50. B. Gusterson, M.J. Warburton, D. Mitchell, Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast disease, Cancer research, 1982; 42: 4763-4770. Cerca con Google

51. K.A. Hahn, L. Bravo, J.S. Avenell, Feline breast carcinomas as a pathologc and therapeutic model for human breast cancer, In Vivo, 1994, 8: 825-828. Cerca con Google

52. J.M Hamilton, R.W. Else, P. Forshaw: Oestrogen receptor in feline mammary carcinomas. Veterinary Research, 1976, 99: 477-479. Cerca con Google

53. J.F. HAMPE, W. MISDORP, Tumours and dysplasia of the mammary gland, Bull World Health Organ, 1974, 50: 111-113. Cerca con Google

54. D.W. Hayden, S.W. Nielsen, Feline mammary tumors, Small Animal Practice, 1971, 12: 687-98. Cerca con Google

55. H.M.Jr. Hayes, K.L. Milne, C.P. Mandell, Epidemiological features of feline mammary carcinoma, Veterinary Record, 1981, 108: 476-479. Cerca con Google

56. T.A. Hopp, S.A.W. Fuqua, Estrogen receptor variants. Journal of Mammary Gland Biology and Neoplasia, 1998, 3 (1): 73-83. Cerca con Google

57. T. Ito, T. Kadosawa, M. Mochizuki, S. Matsunnaga, R. Nishimura, N. Sasaki: Prognosis of malignant mammary tumors in 53 cats, Journal of Veterinary Medical Science, 1996, 58(8): 723- 726. Cerca con Google

58. A.D. Jarasch, R.B. Nagle, M. Kaufmann, C. Maurer, W.J. Bocker, Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins, Human Pathology, 1988, 19; 276-289. Cerca con Google

59. D.A. Kamstock., D.A. Kamstock, R. Fredrickson, E.J. Ehrhart: Lipid-rich Carcinoma of the Mammary Gland in a Cat; Veterinary Pathology 2005, 42:360–362. Cerca con Google

60. P.Kastner, A.Krust, B.Turcotte, U.Stropp, L.Tora, H.Gronemeyer and P.Chambon, Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B, The EMBO Journal, 1990, 9(5): 1603 – 1614- Cerca con Google

61. S.R. Lakhani, R.Chaggar, S. Davies, Genetic alterations in ‘normal’ luminal and myoepithelial cells of the breast, The Journal of Pathology, 1999, 189: 496–503. Cerca con Google

62. D. Lazard, X. Sastre, M.G. Frid, M.A. Glukhova, J.P. Thiery, V.E. Koteliansky, Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue, Proceedings of the National Academy of Sciences of the United States of America, 1993, 1;90(3): 999-1003. Cerca con Google

63. S.A. Leonhardt, V. Boonyaratanakornkit, D.P. Edwards. Progesterone receptor transcription and non-transcription signaling mechanisms, Steroids, 2003, 68(10-13): 761-70. Cerca con Google

64. T.Y.M. Leong, A.S.Y. Leong, Review Article, Controversies in the Assessment of HER-2, More questions Than Answers, Advances in anatomic pathology, 2006, 13: 263-269. Cerca con Google

65. E. Lerma, G. Peiro, T. Ramón, S. Fernandez, D. Martinez, C. Pons, F. Muñoz, J.M. Sabate, C. Alonso, B. Ojeda, J. Prat, A. Barnadas, Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas), Modern Pathology, 2007, 20(11):1200-7. Cerca con Google

66. A.J. Levine,W. Hu, Z. Feng, The p53 pathway: what questions remain to be explored?, Cell Death and Differentiation, 2006, 13: 1027-1036. Cerca con Google

67. C.A. Livasy, G. Karaca, R. Nanda, M.S. Tretiakova, O.I. Olopade, D.T. Moore, C.M. Perou, Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma, Modern Pathology, 2006, 19(2): 264-71. Cerca con Google

68. J.P. Lydon, F.J. DeMayo, C.R. Funk, S.K. Mani, A.R. Hughes, Mice lacking progesterone receptor exhibit pleiotropic reproductive anormalities, Gene Development, 1995, 9: 2266-2278. Cerca con Google

69. E.G. MacEwen: Spontaneous tumors in dogs and cats: Model for the study of cancer biology and treatment, Cancer and Metastasis Reviews, 1990, 9: 125-136. Cerca con Google

70. E.G. MacEwen, A.A. Hayes, J. Harvey, A.K. Patnaik, S. Mooney, S. Passe: Prognostic factors for feline mammary tumors. Journal of American Veterinary Medical Association, 1984, 185 (2): 201- 204. Cerca con Google

71. E.G. MacEwen, S.J. Withrow: Tumors of the mammary gland. Small Animal Clinical Oncology, Eds. W.B. Daunders, London, 1996 pp 356-379. Cerca con Google

72. B.S. McEwen, Non-genmomic and genomic effects of steroids on neural activity. Trends in pharmacological sciences, 1991, 12: 141–147. Cerca con Google

73. Malzahn, M. Mitze, M. Thoenes, R. Moll, Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas, Virchows Arch, 1998, 433: 119-129. Cerca con Google

74. Martín de las Mulas, A. Espinosa de los Monteros, M.J. Bautista, J.C. Gómez-Villamandos, Morales C Immunohistochemical distribution pattern of intermediate filament proteins and muscle actin in feline and human mammary carcinomas, Journal of Comparative Pathology, 1994, 111(4): 365-81. Cerca con Google

75. J. Martín de las Mulas, M. Van Niel, Y. Millán, J. Ordás, M.A. Blankenstein, F. Van Mil, W. Misdorp, Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status, Research in Veterinary Science 2002, 72: 153-161. Cerca con Google

76. J. Martin De las Mulas, J. Ordàs, Y. Millàn, V. Fernàndez-Soria, S. Ramòny Cajal, Oncogene HER- 2 in canine mamary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study, Breast Cancer Research and Treatment, 2003, 80(3): 363-7. Cerca con Google

77. P.M. Martin, M. Cotard, J.P. Mialot, F. André, J.P. Raynaud, Animal models for hormonedependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate, Cancer Chemotherapy and Pharmacology, 1984, 12(1): 13-7. Cerca con Google

78. B. Mayr, J. Blauesteiner, A. Edlinger, M. Reifinger, K. Alton, G. Schaffner, G. Brem, Presence of p53 mutation in feline neoplasms, Research in Veterinary Science, 2000, 68(1): 63-70. Cerca con Google

A. Michalczyk, R.W. Brown, J.P. Collins, Lactating affects expression of intermediate filaments in human breast epithelium. Differentiation, 2000, 67: 41-4. Cerca con Google

79. Migliaccio, D. Piccolo, G. Castoria, M. Di Domenico, A. Bilancio, M. Lombardi, Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor, EMBO Journal, 1998, 17: 2008–2018. Cerca con Google

80. F. Millanta, M. Calandrella, S. Citi, D. Della Santa, A. Poli, Overexpression of HER-2 in Feline Invasive Mammary Carcinomas: An Immunohistocheimical Survey and Evaluation of Its Prognostic Potential, Veterinary Pathology, 2005, 42: 30-34. Cerca con Google

81. F. Millanta, G. Lazzeri, M. Mazzei, I. Vannozzi, A. Poli, MIB-1 Labeling Index in Feline Dysplastic and Neoplastic Mammary Lesions and Its Relationship with Postsurgical Prognosis, Veterinary Pathology, 2002, 39: 120-126. Cerca con Google

82. F. Millanta, M. Calandrella, G. Bari, M. Niccolini, I. Vannozzi, A. Poli, Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues, Research in Veterinary Science,2005, 79(3): 225-32. Cerca con Google

83. F. Millanta, M. Calandrella, I. Vannozzi, A. Poli, Steroid hormone receptors in normal, dysplastic and feline mammary tissues and their prognostic significance, Veterinary Research, 2006,158(24): 821-4. Cerca con Google

84. W. Misdorp: Immunoistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay. Domestic Animal Endocrinology, 18: 111-125, 2000. Cerca con Google

85. W. Misdorp: Tumors in domestic animals (D.J.Meuten Editor), capitolo12, pp.575-607. Iowa State University Press, Ames IA, 4th edition, 2002. Cerca con Google

86. W. Misdorp, R.W. Else, E. Hellmèn, T.P. Lipscomb, Histological classification of mammary tumors of the dog and cat. In WHO International Histological Classification of Tumors of Domestic Animals, volume 7 di 2nd, Armed Force Institute of Pathology, American Registry of Pathology, 2001. Cerca con Google

87. J.A. Mol, E. Van Garderen, G.R. Rutterman, A. Rijnberk, New insight in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local byosynthesis of growth hormone (GH) in the mammary glands of dogs, cats end humans, J Steroid Biochemical Mol Biol, 1996, 57(1-2): 67-71. Cerca con Google

88. R. Moll, W.W. Franke, D.L. Schiller, The catalog of human cytokeratins: patterns of expression in normal epiythelia, tumors and cultured cells; Cell, 1982, 31: 11-24. Cerca con Google

89. U.M. Moll, G. Riou, A.J. Levine, Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion, Proceedings of the National Academy of Sciences of the United States of America 1992, 89(15): 7262-6. Cerca con Google

90. J.S. Morris, C. Nixon, A. Bruck, L. Nasir, I.M. Morgan, A.W. Philbey, Immunohistochemical Cerca con Google

91. expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ER? and p53, 2007, The Veterinary Journal, doi: 10.1016/j.tvjl.2007.01.006. Cerca con Google

92. P.A. Mote, S. Bartow, N. Tran, C.L. Clarke, Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis, Breast Cancer Research and Treatment, 2002, 72:163-172. Cerca con Google

93. Mrhalovà, R. Kodet, M. Kalinovà, I. Hilskà, Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: correlation with ERBB-2 protein expression and ERBB2 gene copy number, Pathology, Research and Practice, 2003, 199(7): 453-61. Cerca con Google

94. Y. Murakami, S. Tateyama, A.Rungsipipat, K. Uchida, R. Yamaguchi, Immunohistochemical Analysis of Cyclin D1 and P53 in mammary Tumors,Squamous Cell Carcinomas and Basal Cell tumors of Dogs and Cats, J. Vet. Med. Sci, 2000, 62(7): 743-750. Cerca con Google

95. Nakano, H. Wu, Y. Taura, M. Inoue, Immunohistochemical Detection of Mdm2 and p53 in Feline Mammary Gland Tumors, The Journal of Veterinary Medical Science, 2005, 68(5): 421-425. Cerca con Google

96. L. Nasir, H. Krasner, D.J. Argyle, A. Williams, Immunocytochemical analysis of the tumour suppressor protein (p53) in feline neoplasia, Cancer Letters, 1999, 155 :1-7. Cerca con Google

97. R. Nickel R, A. Schummer, E. Seiferle, Trattato di Anatomia degli Animali Domestici, 1992 Vol III. Cerca con Google

98. Okuda, A. Umeda, T. Sakai, T. Ohashi, Y. Momoi, H.Y. Youn, T. Watari, R. Goitsuka, H. Tsujimoto, A. Hasegawa, Cloning of feline p53 tumor-suppressor gene and its aberration in hematopietic tumors, International Journal of Cancer, 1994, 58(4): 602-7. Cerca con Google

99. D.A. Olsen, B. Ostergaard, S. Bokmand, P.A. Wamberg, E.H. Jakobsen, I. Brandslund, HER-2 protein concentrations in breast cancer cells increase before immunohistochemical and fluorescence in situ hybridization analysis turn positive, Clinical Chemistry and Laboratory Medicine, 2007, 45(2): 177-82. Cerca con Google

100. J. Ordas, Y. Millan, A.E. de los Monteros, C. Reymundo, J. Martin de las Mulas , Immunoistochemical expression of progesterone receptors, growth hormone and insulin growth factor-1 in feline fibroadenomatous change, Research in Veterinary Science, 2004, 76(3): 227-33. Cerca con Google

101. F. Otterbach, A. Bankfalvi, F.M. Bergner, T. Decker, R. Krech, W. Boecker, Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferation of the breast, Histopathology, 2000, 37: 232-240. Cerca con Google

102. Overley, F.S. Shofer, M.H. Goldschmidt, D. Sherer, K.U. Sorenmo, Association between ovarihysterectomy and feline mammary carcinoma, Journal of Veterinary Internal Medicine, 2005, 19(4): 560-3. Cerca con Google

103. L.N. Owen: A comparative study of canine and human breast cancer. Investigative and Cell Pathology 1979; 2(4): 257-275. Cerca con Google

A. Paganini-Hill, P.C. Wan, M.C. Pike, Effect ofhormone replacement therapy on breast cancer risk: Estrog versus estrogen plus progestin, Journal of National Cancer Institute, 2000, 92: 328-332. Cerca con Google

104. J.T. Papadimitriou, M. Stampfer, J. Bartek, A. Lewis, M. Boshell, E.B. Lane, I.M. Leigh, Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium, Journal of Cell Science, 1989, Vol 94(3): 403-413. Cerca con Google

105. Péchoux, T. Gudjonsson, L. Ronnov-Jessen, M.J. Bissell, O.W. Petersen, Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Developmental Biology, 1999, 206(1): 88-99. Cerca con Google

106. C.M. Perou, T. Sørlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S.X. Zhu, P.E. Lønning, A.L. Børresen-Dale, P.O. Brown, D. Botstein, Molecular portraits of human breast tumors, 2000, Nature, 406, 17. Cerca con Google

107. S.S. Pinho, A.J. Matos, C. Lopes, N.T. Marcos, J. Carvalheira, C.A. Reis, F. Gärtner, Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression, BMC Cancer, 2007, 6;7:124. Cerca con Google

108. S.M.R. Pinilla, D. Sarrió, E. Honrado, G. Moreno-Bueno, D. Hardisson, F. Calero, J. Benítez, J. Palacios,Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas, Journal of Clinical Patholog, 2007, 60(9): 1006-12. Cerca con Google

109. L. Pusztai, C. Mazouni, K. Anderson, Y. Wu, W.F. Symmans, Molecular Classification of Breast Cancer: Limitations and Potential, Oncologist, 2006, 11: 868-877. Cerca con Google

110. J.S. Reis-Filho, A.N.J. Tutt, Triple negative tumors: a critical review, Histopathology, 2008, 52: 108-118. Cerca con Google

111. G.R.Ruteman, Hormones and mammary tumour disease in the female dog, In Vivo, 1990, 4: 33-40. Cerca con Google

112. E.A. Sartin, S. Barnes, R.P. Kwapien, L.G. Wolfe, Estrogen and progesteron receptor status of mammary carcinomas and correlation with clinicals outcome in dogs. American Journal of Veterinary Research, 1992, 53: 2196-2200. Cerca con Google

A. Smiech, W. Lopuszy?ski, Z. Nozdryn-P?otnicki, Studies on histogenesis of mixed tumours of the mammary gland in bitches, Polish Journal of Veterinary Sciences, 2002, 5(4): 217-22. Cerca con Google

113. W.C. Powell, D.G. Hicks, N. Prescott, M. Shannon, S.M. Tarr, S. Laniauskas, T. Williams, S. Short, J. Pettay, R. Nagle, D. Dabbs, K. Scott, R. Brown, T. Grogan, P. Roche, R. Tubbs, A new Rabbit monoclonal antibody (4B5) for the Immunohistochemical (IHC) Determination of the HER2 status in Breast Cancer: Comparison Wih CB11, Fluorescence In Situ Hybridization (FISH), and Interlaboratory Reproducibility, 2007, Applied Immunohistochemistry and Molecular Morphology,1062-33. Cerca con Google

114. R. Preziosi, G. Sarli, C. Benazzi, P.S. Marcato, Detection of proliferating cell nuclear antigen (PCNA) in canine and feline mammary tumours, Journal of Comparative Pathology., 1995, 113(4): 301-13. Cerca con Google

115. L. Pusztai, C. Mazouni, K. Andersen, Y. Wu, W.F. Symmans, Molecular classification of breast cancer: limitations and petential; Oncologyst, 2006, 11: 868-877. Cerca con Google

116. F. Raharison, J. Sautet: Lymph drainage of the mammary glands in female cats. Journal of Morphology, 2005: 267(3): 292-299 Cerca con Google

117. L.N. Ramalho, A. Ribeiro-Silva, G.D. Cassali, S. Zucoloto,.Veterinary Pathology, The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms, 2006, 43(4): 424-9. Cerca con Google

118. J.A. Ramos-Vara, Review Article, Technical Aspects of Immunohistochemistry, Veterinary Pathology, 2005, 42: 405-426. Cerca con Google

119. M. Razandi, A. Pedram, G.L. Greene, E.R. Levin, Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ER alpha and ER beta expressed in Chinese hamster ovary cells, Molecular Endocrinoclogy,1999; 13 (2): 307-319. Cerca con Google

120. S. Ricardo, F. Milanezi, S. Cavalho, D. Leitao, F.Schmitt, HER2 Evaluation through the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast cancer carcinomas, Journal of Clinical Pathology, 2006, 60(9): 1001-5. Cerca con Google

121. S. L .Robbins, R.S. Cotran, V. Kumar, Basic Pathology 7th edition, 2003, capitolo 6, pp.166-197. Cerca con Google

122. R.K. Ross, A. Paganini-Hill, P.C. Wan, M.C. Pike, Effect ofhormone replacement therapy on breast cancer risk: Estrog versus estrogen plus progestin, Journal of the National Cancer Institute, 2000, 92: 328-332. Cerca con Google

123. G. Sarli, R. Preziosi, C. Benazzi, R. Bazzo, L. Mandrioli, P.S. Marcato, Rate of apoptosis in feline mammary tumors is not predictive of postsurgical survival, Journal of Veterinary Diagnostic Investigation, 2003, 15: 115-122. Cerca con Google

124. M.J. Scian, K.E.R. Stagliano, M.A. Ellis,S. Hassan, M. Bowman, M.F. Miles, S.P. Deb, S. Deb, Modulation of Gene Expression by Tumor-Derived p53 Mutants, Cancer Research, 2004, 64: 7447- 7454. Cerca con Google

A. Scibelli, D. D’Angelo, A. Pelagalli, S. Tafuri, L. Avallone, R. Della Morte, N. Staiano, Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumors, Vet Res, 2003, 34(2): 193-202. Cerca con Google

125. F. Seixas, M.A. Pires, C.A. Lopes, Veterinary Journal, Complex carcinomas of the mammary gland in cats: Pathological and immunohistochemical features. 2007, 23. Cerca con Google

126. J.A. Shaw, K. Udokang, J.M. Mosqueira, H. Chauhan, J.L. Jones, Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. Journal of Pathology, 2002, 198: 450- 457. Cerca con Google

127. S. Signoretti, L. Di Marcotullio, A. Richardson, Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. Journal of Clinical Investigation. 2002. 110: 633-641. Cerca con Google

128. R. Sitruk-Ware, Progestins in hormonal replacement therapy (HRT): new molecules, risks and benefits, L'Année endocrinologique, 2003, 64(2): 178. Cerca con Google

129. K.A. Skorupski, B. Overley, F.S. Shofer, M.H. Goldschmidt, C.A. Miller, K.U. Sorenmo, Clinical characteristics of mammary carcinoma in male cats, Journal of veterinary internal medicine/American College of Veterinary Internal Medicine, 2005, 19(1): 52-5. Cerca con Google

130. G.H. Smith, D. Medina, A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland, Journal of Cell Science,1988,90: 173-83. Cerca con Google

131. K. Sorenmo, Canine mammary gland tumors, Veterinary Clinics of North American. Small Animal Practice, 2003, 33(3):573-96. Cerca con Google

132. J. Stingl, A. Raouf, J.T. Emerman, C.J. Eaves, Epithelial Progenitors in the Normal Human Mammary gland, Journal of Mammary Gland Biology and Neoplasia, 2005, 10(1). Cerca con Google

133. C.R. Taylor, S.R. Shi, B. Chaiwun, L. Young, S.A. Imam, R.J. Cote, Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques, Human Pathology, 1994, 25(3): 263-70. Cerca con Google

134. O.W. Tawfik, B.F. Kimler, M. Davis,J.K. Donahue, D.L. Persons, F. Fan, S. Hagemeister, P. Thomas, C. Connor, W. Jewell, C.J. Fabian, Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in –situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma, Histopathology, 2006, 48: 258-267. Cerca con Google

135. T. Thomson, M.M. Hayes, J.J. Spinelli, E. Hilland, C. Sawrenko, D. Phillips, B. Dupuis, R.L. Parker, HER-2/neu in Breast Cancer: Interobserver Variability and Performance of Immunoistochemistry with 4 Antibodies Compared with Fluorescent In situ Hybridation, Modern Patholology, 2001, 14(11): 1079-1086. Cerca con Google

136. K. Thriveni,V. Deshmane, P.P. Bapsy, L. Krishnamoorthy, G. Ramaswamy, Clinical utility of serum human epidermal receptors-2/neu detectionin breast cancer patients, 2007, Indian Journal of Medicine Research, 125: 137-42. Cerca con Google

137. J. Tian, S. Kim, E. Heilig and J.V. Ruderman, Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation, Proceedings of the National Academy of Sciences of the United States of America, 2000, 97: 14358–14363. Cerca con Google

138. W. Traut, E. Endl, T. Scholzen, J. Gerdes, H. Winking, The temporal and spatial distribution of the proliferation associated Ki-67 protein during female and male meiosis, Chromosoma, 2002, Vo 111, No 3, pp.156-164 Cerca con Google

139. R.R. Tubbs,J.D. Pettay, P.C. Roche, M.H. Stoler, R.B. Jenkins, T.M. Grogan, Discrepancies in Clinical Laboratory Testing of Eligibility for Trastuzumab Therapy:Apparent Immunohistochemical False-Positive Do Not Get the Message, Journal of Clinical Oncology, 2001, 19: 2714-2721. Cerca con Google

A. Urruticoechea, I.E. Smith, M. Dowsett, Proliferation Marker Ki-67 in Early Breast Cancer, Journal of Clinical Oncology, 2005, Vol 23, No 28, pp.7212-7220. Cerca con Google

140. D.M. Vail, E.G. MacEwen: Spontaneous occurring tumors of companion animals as models of human cancer, Cancer Investigation, 2000, 18 (8):781-792. Cerca con Google

141. U. Vijapurkar, M.S. Kim ,J.G. Koland, Roles of mitogen-activated protein kinase and phosphoinositide 3’-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling, Experimental Cell Research, 2003, 284(2): 291-302. Cerca con Google

142. J.G. Vilches-Moure, J.A. Ramos-Vara, Comparison of rabbit monoclonal and mouse monoclonal antibodies in immunohistochemistry in canine tissue, Journal of Veterinary Diagnostic Investigation, 2005, 17: 346-350. Cerca con Google

143. R.J. Viste, S.L. Myers, B. Singh, E. Simko, Feline mammary adenocarcinoma: tumor size as a prognostic indicator, The Canadian Veterinary Journal, 2002, 43(1): 33-37. Cerca con Google

144. J.H. Vos, T.S. van den Ingh, W. Misdorp, R.F. Molenbeek,F.N. van Mil, G.R. Rutteman, D. Ivanyi, F.C. Ramaekers, Immunohistochemistry with keratin, vimentin, desmin, and alpha-smooth muscle actin monoclonal antibodies in canine mammary gland: malignant mammary tumours,Vet Q, 1993, 15(3): 96-102. Cerca con Google

145. J.D. Webster, V. Yuzbasiyan-Gurkan, R.A. Miller, J.B. Kaneene, M. Kiupel: Cellular Proliferation in Canine Cutaneous Mast Cell Tumors: Associations with c-KIT and Its Role in Prognostication, Veterinary Pathology, 2007, 44: 298-308. Cerca con Google

146. K. Weijer, A.A.M. Hart: Prognostic factors in feline mammary carcinoma. Journal of the National Cancer Institute, 1983, 70 (4): 709-716. Cerca con Google

147. K. Weier, K.W. Head, W. Misdorp, J.F. Hampe: Feline malignant mammary tumors I. Morphology and biology: some comparisons with human and canine mammary carcinomas. Journal of the National Cancer Institute, 1972, 49: 1697-1704. Cerca con Google

148. J.M. Williams, C.W. Daniel, Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis, Developmental Biology, 1983, 97(2): 274-90. Cerca con Google

149. S.J. Winder, M.P. Walsh, Calponin: Thin filament-linked regulation of smooth muscle contraction, Cell Signaling, 1993, 5: 677-686. Cerca con Google

150. J. Winston, D.M. Craft, T.J. Scase, P.J. Bergman, Immunohistochemical detection of HER-2/neu expression in spontaneous feline mammary tumours, Veterinary and Comparative Oncology, 2005, 3(1): 8-15. Cerca con Google

151. A.C. Wolff, M.E. Hammond, J.N. Schwartz, K.L. Hagerty, D.C. Allred, R.J. Cote, M. Dowsett, P.L. Fitzgibbons, W.M. Hanna, A. Langer, L.M. McShane, S. Paik, M.D. Pegram, E.A. Perez, M.F. Press, A. Rhodes, C. Sturgeon, S.E. Taube, R. Tubbs, G.H. Vance, M. van de Vijer, T.M. Wheeler, D.F. Hayes, American Society of Clinical Oncology, College of American Pathologists guideline raccomandations for human epidermal growth factors receptor 2 testing in breast cancer, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 2007, 25(1): 118-45. Cerca con Google

152. H. Yaziji, A.M. Gown, N. Sneige, Detection of stromal invasion in breast cancer: myoepthelial markers, Advances in Anatomic pathology, 2000, 7:100-109. Cerca con Google

153. V. Zappulli, G. De Zan, B. Cardazzo, L. Bargelloni, M. Castagnaro, Feline mammary tumors in comparative oncology, Journal of Dairy Research, 2005, 72: 98-106. Cerca con Google

154. G.H. Zhang, W.T. Yang, X.Y. Zhou, Y. Zeng, H.F. Lu, D.R. Shi, Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer, Zhonghua Yi Xue Za Zhi, 2007, 87(3): 155-60. Cerca con Google

Download statistics

Solo per lo Staff dell Archivio: Modifica questo record